• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性醛固酮增多症患者骨密度降低的相关危险因素。

Risk Factors Associated With Lower Bone Mineral Density in Primary Aldosteronism Patients.

机构信息

Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Department of Radiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Front Endocrinol (Lausanne). 2022 Jun 16;13:884302. doi: 10.3389/fendo.2022.884302. eCollection 2022.

DOI:10.3389/fendo.2022.884302
PMID:35784563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9245341/
Abstract

PURPOSE

The association between primary aldosteronism (PA) and lower bone mineral density (BMD) has raised a concern, but the contributing factors remain unclear. We aim to explore the risk factors for lower BMD in PA patients.

METHODS

We analyzed and compared the data of 60 PA patients with 60 matched essential hypertension (EH) patients. BMD, bone metabolites, and several oxidative stress and inflammation indicators-including C-reactive protein (CRP), superoxide dismutase (SOD), total bilirubin (TBIL), mean platelet volume (MPV), -were assessed and compared in PA and EH patients. Bivariate correlation analysis and multivariate linear regression analysis were performed to explore the factors associated with BMD in PA patients.

RESULTS

The BMD measured by quantitative computed tomography in PA patients was lower than that in EH patients (141.9 ± 34.0 vs. 158.9 ± 55.9 g/cm, = 0.047), especially in patients less than 50 years old. BMD was independently negatively associated with age (standardized = -0.581, < 0.001), serum phosphorus (standardized = -0.203, = 0.008), urinary calcium excretion (standardized = -0.185, = 0.031), and MPV (standardized = -0.172, = 0.043) and positively associated with SOD (standardized = 0.205, = 0.011) and TBIL (standardized = 0.212, = 0.015).

CONCLUSIONS

The PA patients showed a lower BMD than the EH patients, which was associated with age, serum phosphorus, urinary calcium excretion, MPV, SOD, and TBIL. These variables might be potential markers for the assessment of bone loss and efficacy of treatments in PA patients.

摘要

目的

原发性醛固酮增多症(PA)与较低的骨密度(BMD)之间存在关联,这引起了人们的关注,但导致这种关联的因素仍不清楚。我们旨在探讨 PA 患者 BMD 降低的相关危险因素。

方法

我们分析并比较了 60 例 PA 患者和 60 例匹配的原发性高血压(EH)患者的数据。评估并比较了 PA 和 EH 患者的 BMD、骨代谢物以及几种氧化应激和炎症指标,包括 C 反应蛋白(CRP)、超氧化物歧化酶(SOD)、总胆红素(TBIL)、平均血小板体积(MPV)。采用双变量相关分析和多元线性回归分析探讨与 PA 患者 BMD 相关的因素。

结果

PA 患者定量计算机断层扫描(QCT)测量的 BMD 低于 EH 患者(141.9 ± 34.0 与 158.9 ± 55.9 g/cm³, = 0.047),尤其是年龄小于 50 岁的患者。BMD 与年龄(标准化β = -0.581, < 0.001)、血清磷(标准化β = -0.203, = 0.008)、尿钙排泄量(标准化β = -0.185, = 0.031)和 MPV(标准化β = -0.172, = 0.043)呈负相关,与 SOD(标准化β = 0.205, = 0.011)和 TBIL(标准化β = 0.212, = 0.015)呈正相关。

结论

PA 患者的 BMD 低于 EH 患者,与年龄、血清磷、尿钙排泄量、MPV、SOD 和 TBIL 相关。这些变量可能是评估 PA 患者骨丢失和治疗效果的潜在标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b79/9245341/c78ccaf32dda/fendo-13-884302-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b79/9245341/c78ccaf32dda/fendo-13-884302-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b79/9245341/c78ccaf32dda/fendo-13-884302-g001.jpg

相似文献

1
Risk Factors Associated With Lower Bone Mineral Density in Primary Aldosteronism Patients.原发性醛固酮增多症患者骨密度降低的相关危险因素。
Front Endocrinol (Lausanne). 2022 Jun 16;13:884302. doi: 10.3389/fendo.2022.884302. eCollection 2022.
2
Bone and mineral metabolism in patients with primary aldosteronism: A systematic review and meta-analysis.原发性醛固酮增多症患者的骨与矿物质代谢:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2022 Oct 31;13:1027841. doi: 10.3389/fendo.2022.1027841. eCollection 2022.
3
Bone health and aldosterone excess.骨骼健康与醛固酮过多症。
Osteoporos Int. 2013 Nov;24(11):2801-7. doi: 10.1007/s00198-013-2399-1. Epub 2013 May 22.
4
Different roles of the RAAS affect bone metabolism in patients with primary aldosteronism, Gitelman syndrome and Bartter syndrome.RAAS 的不同作用会影响原发性醛固酮增多症、Gitelman 综合征和 Bartter 综合征患者的骨代谢。
BMC Endocr Disord. 2022 Feb 11;22(1):38. doi: 10.1186/s12902-022-00955-2.
5
[Comparison on metabolic disorders and uric acid levels between patients with primary aldosteronism and essential hypertension].原发性醛固酮增多症与原发性高血压患者代谢紊乱及尿酸水平的比较
Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Sep 24;44(9):743-749. doi: 10.3760/cma.j.issn.0253-3758.2016.09.003.
6
Improvement of bone turnover markers and bone mineral density following treatment of primary aldosteronism.原发性醛固酮增多症治疗后骨转换标志物及骨密度的改善
Minerva Endocrinol. 2018 Jun;43(2):117-125. doi: 10.23736/S0391-1977.16.02553-0. Epub 2016 Dec 20.
7
Mean platelet volume is negatively associated with bone mineral density in postmenopausal women.血小板平均体积与绝经后妇女的骨密度呈负相关。
J Bone Miner Metab. 2012 Nov;30(6):660-5. doi: 10.1007/s00774-012-0362-4. Epub 2012 Jun 9.
8
Bone involvement in aldosteronism.醛固酮症中的骨骼受累。
J Bone Miner Res. 2012 Oct;27(10):2217-22. doi: 10.1002/jbmr.1660.
9
Elevated Myoglobin in Patients With Primary Aldosteronism: A Cross-Sectional Study.原发性醛固酮增多症患者肌红蛋白升高:一项横断面研究。
Front Endocrinol (Lausanne). 2022 Feb 21;13:799174. doi: 10.3389/fendo.2022.799174. eCollection 2022.
10
Bone and mineral metabolism in patients with primary aldosteronism.原发性醛固酮增多症患者的骨与矿物质代谢。
Int J Endocrinol. 2014;2014:836529. doi: 10.1155/2014/836529. Epub 2014 Apr 3.

引用本文的文献

1
Association of Mean Platelet Volume Expression with Bone Mineral Density in Patients with T2DM and CKD.2型糖尿病和慢性肾脏病患者平均血小板体积表达与骨密度的相关性
Int J Gen Med. 2025 Aug 5;18:4239-4249. doi: 10.2147/IJGM.S535847. eCollection 2025.
2
Causal effects of primary aldosteronism on inflammation and bone density: evidence from Mendelian randomization, animal, and clinical studies.原发性醛固酮增多症对炎症和骨密度的因果效应:来自孟德尔随机化、动物及临床研究的证据
Diabetol Metab Syndr. 2025 Jul 30;17(1):303. doi: 10.1186/s13098-025-01875-6.
3
The prevalence of metabolic syndrome in primary aldosteronism and essential hypertension: A systematic review and meta-analysis.

本文引用的文献

1
Bone mineral density modeling via random field: Normality, stationarity, sex and age dependence.基于随机场的骨密度建模:正态性、平稳性、性别和年龄依赖性。
Comput Methods Programs Biomed. 2021 Oct;210:106353. doi: 10.1016/j.cmpb.2021.106353. Epub 2021 Aug 19.
2
Primary Aldosteronism and Bone Metabolism: A Systematic Review and Meta-Analysis.原发性醛固酮增多症与骨代谢:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2020 Sep 25;11:574151. doi: 10.3389/fendo.2020.574151. eCollection 2020.
3
Value of Platelet Distribution Width and Mean Platelet Volume in Disease Activity Score of Rheumatoid Arthritis.
原发性醛固酮增多症和原发性高血压中代谢综合征的患病率:系统评价和荟萃分析。
J Clin Hypertens (Greenwich). 2024 Aug;26(8):879-889. doi: 10.1111/jch.14873. Epub 2024 Jul 22.
4
Correlation between plasma aldosterone concentration and bone mineral density in middle-aged and elderly hypertensive patients: potential impact on osteoporosis and future fracture risk.中老年高血压患者血浆醛固酮浓度与骨密度的相关性:对骨质疏松症和未来骨折风险的潜在影响。
Front Endocrinol (Lausanne). 2024 May 14;15:1373862. doi: 10.3389/fendo.2024.1373862. eCollection 2024.
5
Bilateral or Unilateral Aldosterone Hypersecretion and Responsiveness to Therapy Are Associated with Differences in Calcium/Phosphate Homeostasis in Patients with Primary Aldosteronism.双侧或单侧醛固酮分泌过多及对治疗的反应与原发性醛固酮增多症患者钙/磷稳态的差异相关。
Intern Med. 2024 Oct 1;63(19):2605-2612. doi: 10.2169/internalmedicine.3116-23. Epub 2024 Feb 26.
6
Cross-Disciplinary Approach of Adrenal Tumors: Insights into Primary Aldosteronism-Related Mineral Metabolism Status and Osteoporotic Fracture Risk.肾上腺肿瘤的跨学科研究:原发性醛固酮增多症相关矿物质代谢状态与骨质疏松性骨折风险的深入探讨。
Int J Mol Sci. 2023 Dec 11;24(24):17338. doi: 10.3390/ijms242417338.
7
The Entity of Connshing Syndrome: Primary Aldosteronism with Autonomous Cortisol Secretion.康欣综合征的实体:原发性醛固酮增多症伴自主性皮质醇分泌。
Diagnostics (Basel). 2022 Nov 13;12(11):2772. doi: 10.3390/diagnostics12112772.
血小板分布宽度和平均血小板体积在类风湿关节炎疾病活动评分中的价值
J Inflamm Res. 2020 Sep 25;13:595-606. doi: 10.2147/JIR.S265811. eCollection 2020.
4
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension.原发性醛固酮增多症的遗传学、患病率、筛查与确诊:欧洲高血压学会内分泌性高血压工作组的立场声明与共识
J Hypertens. 2020 Oct;38(10):1919-1928. doi: 10.1097/HJH.0000000000002510.
5
Osteoporosis in Older Adults.老年人骨质疏松症。
Med Clin North Am. 2020 Sep;104(5):873-884. doi: 10.1016/j.mcna.2020.06.004. Epub 2020 Jul 15.
6
Role of the renin-angiotensin-aldosterone system in bone metabolism.肾素-血管紧张素-醛固酮系统在骨代谢中的作用。
J Bone Miner Metab. 2020 Nov;38(6):772-779. doi: 10.1007/s00774-020-01132-y. Epub 2020 Jul 30.
7
The Prevalence of Osteoporosis in China, a Nationwide, Multicenter DXA Survey.中国骨质疏松症患病率的全国性、多中心 DXA 调查。
J Bone Miner Res. 2019 Oct;34(10):1789-1797. doi: 10.1002/jbmr.3757. Epub 2019 Aug 29.
8
High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan.原发性醛固酮增多症(PA)伴亚临床皮质醇增多症患者中糖尿病患病率高,双侧比单侧 PA 患者更易发生糖尿病前期:日本一项大型多中心队列研究。
Diabetes Care. 2019 May;42(5):938-945. doi: 10.2337/dc18-1293.
9
Osteoporosis and the Ageing Skeleton.骨质疏松症与衰老骨骼
Subcell Biochem. 2019;91:453-476. doi: 10.1007/978-981-13-3681-2_16.
10
Postmenopausal osteoporosis is associated with elevated aldosterone/renin ratio.绝经后骨质疏松症与醛固酮/肾素比值升高有关。
J Hum Hypertens. 2018 Jul;32(7):524-530. doi: 10.1038/s41371-018-0069-7. Epub 2018 May 22.